A multi-agent system for detecting adverse drug reactions

Discovering unknown adverse drug reactions (ADRs) as early as possible is highly desirable. Current methods largely rely on passive spontaneous reports, which suffer from serious underreporting, latency, and inconsistent reporting. They are not ideal for early identification of ADRs [5]. In this paper, we propose a multi-agent system approach for ADR detection. A multi-agent system is formed by a community of agents that exchange information and proactively help one another to achieve the goals set by the system designer. We show how agents, equipped with decision rules developed by the physicians on the team, can collaborate to detect signal pairs of potential ADRs. Using the popular agent language JADE [8, 10] and clinical information on 1,000 patients treated at the Detroit Veterans Affairs Medical Center, we have constructed a small group of agents and generated preliminary simulated detection results.

[1]  Yun Peng,et al.  Agent communication languages: the current landscape , 1999, IEEE Intell. Syst..

[2]  Robert Orchard,et al.  Fuzzy Reasoning in JESS: The Fuzzyj Toolkit and Fuzzyjess , 2001, ICEIS.

[3]  S. Evans,et al.  Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports , 2001, Pharmacoepidemiology and drug safety.

[4]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[5]  Giovanni Caire,et al.  JADE Programmer's Guide , 2002 .

[6]  Munindar P. Singh Agent Communication Languages: Rethinking the Principles , 1998, Computer.

[7]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[8]  J. Yen,et al.  Extending Recognition-Primed Decision Model For Human-Agent Collaboration , 2005 .

[9]  John Yen,et al.  A distributed adverse drug reaction detection system using intelligent agents with a fuzzy recognition‐primed decision model , 2007, Int. J. Intell. Syst..

[10]  Salceda J. Vazquez Role of Norms and Electronic Institutions in Multi-Agent Systems: The Harmonia Framework , 2004 .

[11]  Raymond S. T. Lee Fuzzy-Neuro Approach to Agent Applications , 2005 .

[12]  Kay Brune,et al.  Lack of Awareness of Community-Acquired Adverse Drug Reactions Upon Hospital Admission , 2003, Drug safety.

[13]  D. Klein,et al.  The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children , 2006, Neuropsychopharmacology.

[14]  Marc Esteva,et al.  Institutionalising open multi-agent systems , 2000, Proceedings Fourth International Conference on MultiAgent Systems.

[15]  John Yen,et al.  Extending the recognition-primed decision model to support human-agent collaboration , 2005, AAMAS '05.

[16]  Agostino Poggi,et al.  Developing Multi-agent Systems with JADE , 2007, ATAL.

[17]  Marc Esteva,et al.  Institutionalizing Open Multi-Agent Systems. , 2000 .

[18]  S. Goldman,et al.  Limitations and strengths of spontaneous reports data. , 1998, Clinical therapeutics.

[19]  Pawel Kaczmarek,et al.  Testing the efficiency of JADE agent platform , 2004, Third International Symposium on Parallel and Distributed Computing/Third International Workshop on Algorithms, Models and Tools for Parallel Computing on Heterogeneous Networks.

[20]  Javier Vázquez-Salceda,et al.  The Role of Norms and Electronic Institutions in Multi-Agent Systems , 2003, Whitestein Series in Software Agent Technologies.

[21]  Hong Lin Architectural Design of Multi-Agent Systems: Technologies and Techniques , 2007 .